| Letrozole beats tamoxifen in breast cancer trial: a switch back to tamoxifen for the remainder of their 5 years would not compromise their outcome.(WOMEN'S ... An article from: Internal Medicine News | Digitalby Bruce Jancin (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 4 Pages | | Publication Date: | February 15, 2009 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on February 15, 2009. The length of the article is 983 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Letrozole beats tamoxifen in breast cancer trial: a switch back to tamoxifen for the remainder of their 5 years would not compromise their outcome.(WOMEN'S HEALTH)Author: Bruce JancinPublication: Internal Medicine News (Magazine/Journal)Date: February 15, 2009Publisher: International Medical News GroupVolume: 42 Issue: 4 Page: 18(1)Distributed by Gale, a part of Cengage Learning |
|
